Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Enfuvirtide acetate bulk supplier for pharma manufacturers

Enfuvirtide Acetate 90 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 90 mg/vial

Reference Brands: Fuzeon (USA/EU)

Category: Anti Viral

Enfuvirtide is an antiretroviral drug used in the treatment of HIV-1 infection in combination with other antiretroviral agents. It is a fusion inhibitor that prevents the HIV virus from entering human immune cells by blocking the fusion of the viral and cellular membranes. This helps in controlling viral replication and slowing the progression of the infection.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Enfuvirtide Acetate — third party manufacturing & bulk supply

Enfuvirtide Acetate 90 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Enfuvirtide Acetate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Enfuvirtide Acetate →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Enfuvirtide acetate is used to treat HIV-1 infection in adults and children, particularly those who have developed resistance to other antiretroviral drugs.

Enfuvirtide acetate is made from a synthetic 36-amino acid peptide that inhibits the fusion of HIV-1 with host cells, combined with acetic acid to form its acetate salt.

The trade name of Enfuvirtide acetate is Fuzeon.

Enfuvirtide acetate is manufactured by Roche and Trimeris under the brand name Fuzeon.

The generic name is Enfuvirtide acetate.

The brand name is Fuzeon.

Enfuvirtide acetate is manufactured in Switzerland and the United States by Roche and its associated production partners for global HIV treatment markets.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.